News Daily News SOUL: Oral Semaglutide Cuts CV Events in Diabetic Patients L.A. McKeown October 23, 2024
News Conference News EACTS 2024 At EACTS 2024, Surgeons and Cardiologists Move Past EXCEL Firestorm Yael L. Maxwell October 22, 2024
News Conference News EACTS 2024 TAVI Explant Complications a ‘Big Issue’ as Procedure Numbers Climb Yael L. Maxwell October 21, 2024
News Daily News Standing Alone Will Not Offset Sitting’s CVD Risks, Study Suggests Todd Neale October 21, 2024
News Conference News EACTS 2024 ‘Teleprehabilitation’ Before Cardiac Surgery Improves the Outcomes That Follow Yael L. Maxwell October 17, 2024
News Opinion Editor's Corner TCT 2024 What’s Going to Be Big at TCT 2024? Michael O'Riordan October 17, 2024
News Conference News EACTS 2024 AI-Based CT Can Accurately Screen Patients for TMVR Yael L. Maxwell October 15, 2024
News Daily News Study Validates Accuracy of PREVENT for CVD Mortality Risk Prediction Todd Neale October 15, 2024
News Daily News More Trees Means Less CVD, Florida Census Data Suggest Yael L. Maxwell October 15, 2024
News Daily News AHA Statement Outlines Cardiac Contributions to Brain Health L.A. McKeown October 11, 2024
News Daily News SCAI Releases Practical, Technical Advice for Primary PCI in STEMI Michael O'Riordan October 10, 2024
News Conference News EACTS 2024 Will Semaglutide Change Cardiac Surgery? It Already Has Yael L. Maxwell October 10, 2024
News Daily News AI-Measured Breast Artery Calcification Tied to CV Outcomes in Women Todd Neale October 07, 2024
News Daily News Time-Restricted Eating Tightens Glycemic Control in Patients With Metabolic Syndrome Caitlin E. Cox October 04, 2024
News Conference News HFSA 2024 Biomarker and Echo Data Bolster Vutrisiran’s Promise in ATTR-CM L.A. McKeown October 04, 2024
News Conference News HFSA 2024 EXPANDed: Atrial Secondary MR Patients Get Clinical Benefit From TEER Caitlin E. Cox October 03, 2024
News Daily News Cramming Weekly Physical Activity Into 1 or 2 Days Still Yields Benefits Michael O'Riordan October 03, 2024
News Conference News HFSA 2024 ‘Metabolic Accelerator’ Cuts Weight, Not Muscle in HFpEF: HuMAIN-HF Michael O'Riordan October 03, 2024
News Conference News HFSA 2024 ‘Global Efficacy’ of Aficamten for Obstructive Disease Shown in SEQUOIA-HCM L.A. McKeown October 02, 2024
News Conference News HFSA 2024 FINEARTS-HF: New Analyses Ask, Who Benefits Most From Finerenone? Michael O'Riordan October 02, 2024